Previous close | 8.05 |
Open | 8.05 |
Bid | 8.14 x 1100 |
Ask | 8.17 x 100 |
Day's range | 7.86 - 8.21 |
52-week range | 1.06 - 11.88 |
Volume | |
Avg. volume | 4,317,801 |
Market cap | 560.468M |
Beta (5Y monthly) | 3.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. During the final months of the year, optimism prevailed due to news of reducing inflation and the potential for lower interest rates in 2024. The fund returned 13.64% (net) […]
C4 Therapeutics, Inc. ( NASDAQ:CCCC ) shareholders will have a reason to smile today, with the analysts making...
C4 Therapeutics ( NASDAQ:CCCC ) Full Year 2023 Results Key Financial Results Revenue: US$20.8m (down 33% from FY 2022...